The lungs as a portal of entry for systemic drug delivery.
about
Inhaled protein/peptide-based therapies for respiratory diseaseNanotechnology-based inhalation treatments for lung cancer: state of the artNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesFundamentals of aerosol therapy in critical careInhaled Antibiotics for Gram-Negative Respiratory InfectionsParticle transport and deposition: basic physics of particle kineticsIsoxyl aerosols for tuberculosis treatment: preparation and characterization of particlesThe role of disposable inhalers in pulmonary drug delivery.Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platformCoverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3).The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies.Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents.A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats.Biologic comparison of inhaled insulin formulations: Exubera™ and novel spray-dried engineered particles of dextran-10.Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics.In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria.Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using (111) Ag as a radiotracer.Albuterol modulates its own transepithelial flux via changes in paracellular permeability.Targeted delivery of liquid microvolumes into the lung.Pulmonary delivery of interleukin-7 provides efficient and safe delivery to the aging immune systemInhaled insulin delivery--where are we now?Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.Aerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.Inhaled Corticosteroids Use Is Not Associated With an Increased Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus: Two Nested Case-Control StudiesLong-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseasesLong-acting preparations of exenatideInhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivoEngineering tissue alternatives to animals: applying tissue engineering to basic research and safety testing.Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation.Dosimetry and toxicology of inhaled ultrafine particles.Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.The development of models for the evaluation of pulmonary drug disposition.Mechanisms of absorption and elimination of drugs administered by inhalation.Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.Occupational health and safety of anti-tumour necrosis factor alpha monoclonal antibodies with casual exposure.Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption.
P2860
Q26751439-07A51630-5A98-4BAA-8023-FFBAE8CBA6DBQ26774177-E75E24C1-5858-4F59-8542-A7C438E3353AQ26786162-E38564EF-5A37-41A7-B40C-8D66EDD6F8F0Q28068836-0985D733-781B-42B2-99EA-5BFB90CC89C4Q28386160-EA101D9E-0CEC-4856-A61A-767F7F0A79F1Q28391883-D80C8DA4-80E9-4AEA-B001-88D4C280BAE4Q28396917-CA811068-E0A8-4424-A6AF-F33105D41575Q30368417-CC99E451-4080-4A16-94FF-64174C683F02Q30386192-A0A2095C-C232-4ACC-9D4E-FDE1487C60C0Q30418520-C7E4A4A9-DB00-439C-B476-2539137F3D53Q33506860-EA4FF277-E8DD-4EA1-A4A6-B264B2F7E70EQ33570456-18EDB578-D717-44C9-B989-9C842DD98C2FQ33835121-BA4D2CD9-E0AB-46F5-B192-999D7D5DBDC1Q34072885-2002B3B4-5B12-46A0-9CE6-F463C80987A4Q34577401-93019F64-2EF7-4238-B16C-1EA1DA3330B7Q34873275-46DB39F7-4E7E-4CDD-A697-83414BD5D826Q35607968-32CD2505-61C3-468B-9B3D-4908B752AB1AQ35688572-89C4C9C3-4C71-4224-B7CF-A919277FEAE7Q35987306-03215674-DB91-4BD7-A74E-CD0F5B565BC4Q36078988-6E8BA226-F719-4687-A522-4808BC6517C7Q36166467-867CE091-2B1A-468A-8E49-C2474D29161EQ36616573-C91C2643-EDA8-4FC4-9F59-D6D9BE85F582Q36618141-B1565811-C609-4531-96A6-55C20EE0D1B4Q36630649-6CFEC7E9-C948-47B9-AB0E-F72B8A364B45Q36988673-70C4CF14-A149-4D55-BEA1-E100FE88ED82Q37103466-AAE8CDFD-3614-4D48-A4AA-DC1D176E52D6Q37167333-A6E53B1C-621C-41E6-B3A0-C271F5BD451CQ37167742-347311FD-EF30-4B0A-8BE7-DD55F543B0C2Q37407977-0779BFEA-36BF-4BEC-8C0C-637A03D1250AQ37442003-98C1A61E-19C0-45A5-9FBB-6C0FCD2D3B1EQ37542225-AD6FCBDF-B091-4612-B035-80BFDA6870D9Q37545580-24240D2A-2378-4A98-85C0-F5064C965FDBQ37551877-ACAD02CC-309C-45BF-B517-D21C7CBC6DD3Q37565681-0051FF37-530D-4A6D-AD41-923921850F91Q37978509-A8EDA19C-094C-42DB-BE79-88397279ED28Q38072075-5EC4FEE6-BB44-4F1B-92E9-75DC0AE36C2BQ38126941-C1008F6C-E101-4C94-94F3-9A86C4473213Q38151858-90B8EAE0-6117-4931-9C1D-6058A7775891Q38160896-9107B1D3-76B2-4816-B1C4-C9EB606CE389Q38168594-C7BE939E-95F2-4496-B211-B2CB680BA7EF
P2860
The lungs as a portal of entry for systemic drug delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The lungs as a portal of entry for systemic drug delivery.
@ast
The lungs as a portal of entry for systemic drug delivery.
@en
type
label
The lungs as a portal of entry for systemic drug delivery.
@ast
The lungs as a portal of entry for systemic drug delivery.
@en
prefLabel
The lungs as a portal of entry for systemic drug delivery.
@ast
The lungs as a portal of entry for systemic drug delivery.
@en
P2093
P1476
The lungs as a portal of entry for systemic drug delivery.
@en
P2093
C Simone Fishburn
Jeffry G Weers
John S Patton
P304
P356
10.1513/PATS.200409-049TA
P577
2004-01-01T00:00:00Z